Mahaney Paige 4
4 · C4 Therapeutics, Inc. · Filed Oct 29, 2024
Insider Transaction Report
Form 4
Mahaney Paige
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-10-28+76,800→ 76,800 total - Award
Stock Option (Right to Buy)
2024-10-28+345,600→ 345,600 totalExercise: $6.00Exp: 2034-10-27→ Common Stock (345,600 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on October 28, 2025, subject to the Reporting Person's continued service on each such vesting date.
- [F2]25% of the shares underlying this option shall vest and become exercisable on October 28, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.